Results 151 to 160 of about 15,511 (169)
Abacavir Pharmacogenetics – From Initial Reports to Standard of Care [PDF]
Pharmacotherapy, 2013 Abacavir is a nucleoside analogue reverse transcriptase inhibitor indicated for the treatment of human immunodeficiency virus infection as part of a multidrug, highly active antiretroviral therapy regimen.
Deanna L. Kroetz
exaly +2 more sources
N-terminal valine adduct from the anti-HIV drug abacavir in rat haemoglobin as evidence for abacavir metabolism to a reactive aldehyde in vivo [PDF]
British Journal of Pharmacology, 2012 BACKGROUND AND PURPOSE The aim of this study was to obtain evidence for the activation of the nucleoside reverse transcriptase inhibitor abacavir to reactive aldehyde metabolites in vivo.
Emília C. Monteiro +2 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Measurement and comprehensive analysis of the solubility of abacavir in twelve pure solvents
Journal of Molecular Liquids, 2021Lina Zhou, Junbo Gong, Chuang Xie
exaly
Risk factor analysis of hypersensitivity reactions to abacavir
Clinical Therapeutics, 2002Amy Cutrell, Seth Hetherington
exaly
Development of albumin-based nanoparticles for the delivery of abacavir
International Journal of Biological Macromolecules, 2015Josephine Leno Jenita
exaly
Abacavir prodrugs: Microwave-assisted synthesis and their evaluation of anti-HIV activities
Bioorganic and Medicinal Chemistry Letters, 2006Dharmarajan Sriram, Perumal Yogeeswari
exaly